Transient hyperpigmentation after calcipotriol ointment and PUVA therapy in psoriatic patients
Vázqvez-López, F.; Pérez-Oliva, N.
Acta Dermato-Venereologica 76(5): 400
1996
ISSN/ISBN: 0001-5555 PMID: 8891019 Document Number: 458278
Document emailed within 1 workday
Related Documents
Borroni, G.; Brazzelli, V.; Fietta, A.; Gatti, M.; Bellosta, M.; Vignati, G.; Zaccone, C.; Berardesca, E.; Rabbiosi, G. 1989: Effects of medium-term PUVA therapy on peripheral T-lymphocyte subsets in psoriatic patients Acta Dermato-Venereologica. Supplementum 146: 125-129Rosdahl, I.K.; Swanbeck, G. 1980: Effects of PUVA on the epidermal melanocyte population in psoriatic patients Acta Dermato-Venereologica 60(1): 21-26
Mom, A.; Aresca, S.; Fuente, G.; Pecorini, V.; Pellerano, G.; Perez, V. 1982: Razoxane in the treatment of psoriatic patients resistant to or intolerant of PUVA, methotrexate and etretinate Acta Dermato-Venereologica 62(4): 357-358
Chodorowska, G.; Czelej, D.; Juszkiewicz-Borowiec, M.; Pietrzak, A.; Wojnowska, D.; Krasowska, D. 1999: Selected cytokines and acute phase proteins in psoriatic patients treated with cyclosporin A or Re-PUVA methods Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 54: 173-180
Duweb, G.; Aldebani, S.; Elzorghany, A.; Benghazil, M.; Alhaddar, J. 2003: Calcipotriol ointment versus cream in psoriasis vulgaris International Journal of Clinical Pharmacology Research 23(2-3): 47-51
Duweb, G.A.; Abuzariba, O.; Rahim, M.; al-Taweel, M.; al-Alem, S.; Abdulla, S.A. 2001: Occlusive versus nonocclusive calcipotriol ointment treatment for palmoplantar psoriasis International Journal of Tissue Reactions 23(2): 59-62
Xing, C.; Xu, A. 2012: The effect of combined calcipotriol and betamethasone dipropionate ointment in the treatment of vitiligo: an open, uncontrolled trial Journal of Drugs in Dermatology: Jdd 11(10): E52-E54
Singh, P.; Gupta, S.; Abidi, A.; Krishna, A. 2013: Comparative evaluation of topical calcipotriol versus coal tar and salicylic acid ointment in chronic plaque psoriasis Journal of Drugs in Dermatology: Jdd 12(8): 868-873
Pinheiro, N. 1997: Comparative effects of calcipotriol ointment (50 micrograms/g) and 5% coal tar/2% allantoin/0.5% hydrocortisone cream in treating plaque psoriasis British Journal of Clinical Practice 51(1): 16-19
Kole, L.; Cantrell, W.; Elewski, B. 2014: A randomized, double-blinded trial evaluating the efficacy and tolerability of vectical ointment (calcitriol 3 mcg/g ointment) when compared to betamethasone diproprionate ointment (64 mg/g) in patients with nail psoriasis Journal of Drugs in Dermatology: Jdd 13(8): 912-915
Szczeklik-Franek, A.; Bober, A.; Kubek, M. 1979: Clinical and histological studies of psoriatic lesions treated with 5% 5-fluorouracil ointment Wiadomosci Lekarskie 32(7): 449-456
Walther, T.; Haustein, U.F. 1990: 8-methoxypsoralen serum content of problem patients in PUVA therapy Dermatologische Monatschrift 176(5-6): 317-321
Salvarani, C.; Lo Scocco, G.; Macchioni, P.; Cremonesi, T.; Rossi, F.; Mantovani, W.; Battistel, B.; Bisighini, G.; Portioli, I. 1995: Prevalence of psoriatic arthritis in Italian psoriatic patients Journal of Rheumatology 22(8): 1499-1503
Fabi, S.; Massaki, N.; Goldman, M.P. 2012: Efficacy and tolerability of two commercial hyperpigmentation kits in the treatment of facial hyperpigmentation and photo-aging Journal of Drugs in Dermatology: Jdd 11(8): 964-968
Kokelj, F.; Lavaroni, G.; Guadagnini, A. 1995: UVB versus UVB plus calcipotriol (MC 903) therapy for psoriasis vulgaris Acta Dermato-Venereologica 75(5): 386-387
2011: Gastric secretory function in psoriatic patients with chronic opistorchosis before and after antihelminthic therapy Klinicheskaia meditsina 89(6): 50-52
Moldenhauer, E.; Dabels, J.; Diwok, K.; Leithäuser, W.; Nowotny, P. 1973: Incidence of liver diseases in psoriatic patients with special reference to methotrexate therapy Dermatologische Monatschrift 159(3): 242-248
E Silva, L.ís.P.C.T.; Luís, F.; Cabrera, H. 2008: Facial hyperpigmentation. amiodarone-induced hyperpigmentation American Family Physician 78(11): 1297-1298
Khardikova, S.A.; Berendeeva, E.P.; Kaliuzhin, V.V.; Beloborodova, E.I. 2009: Diastolic dysfunction of left ventricle in psoriatic patients with concomitant opisthorchiasis before and after antihelminthic therapy Klinicheskaia Meditsina 87(10): 29-32
Ganzetti, G.; Campanati, A.; Bernardini, M.L.; Bettacchi, A.; Brandozzi, G.; Brisigotti, V.; Cataldi, I.; Filosa, G.; Giacchetti, A.; Lemme, G.; Morresi, L.; Nicolini, M.; Postacchini, V.; Ricotti, G.; Rosa, L.; Simonacci, M.; Offidani, A. 2016: The transitioning from conventional therapy to biological treatment in psoriatic patients: STRATOS, a project of Marche Region Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale Societa Italiana di Dermatologia e Sifilografia 151(4): 340-346